S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Apricus Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update|
|Apricus Biosciences Announces Year-End 2014 Update and 2015 Plans to Advance Its Clinical Pipeline and Further Commercialize Its Erectile Dysfunction Drug Vitaros(R)|
|Apricus Biosciences Announces First Patient Enrolled in Phase 2a Clinical Trial for RayVa(TM) in Patients With Raynaud's Phenomenon|
|Apricus Biosciences Announces the Launch of Its Novel Topical Treatment for Erectile Dysfunction in Belgium by Sandoz|
|Apricus Biosciences Appoints Brian T. Dorsey as Chief Development Officer|
|Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer|
|Apricus Biosciences Announces the Appointment of Catherine Bovenizer as Vice President of Finance, Chief Accounting Officer|
|Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)|
|Apricus Biosciences to Present at Biotech Showcase 2015|
|Apricus Biosciences to Present at Three Upcoming Investor Conferences in November and December of 2014|
Click above to view more mutual fund data and stats for apri - Apricus Biosciences Inc.